Lung neoplasmInvasive non-mucinous adenocarcinomaIASLC gradingImagingLung cancer is the leading cause of cancer-related deaths worldwide, with invasive non-mucinous adenocarcinoma (INMA) being the most common type and carrying a poor prognosis. In 2020, the International Association for the Study of ...
Invasive mucinous adenocarcinoma exhibits distinct prognostic outcomes compared to non-mucinous adenocarcinoma (ADC). This study investigated and compared the clinical outcomes and prognostic factors of invasive mucinous and non-mucinous ADC patients. METHODS. This retrospective study included patients who ...
Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer the mutational spectrum of which has been extensively characterized. Treatment of patients with NSCLC based on their molecular profile is now part of the standard clinical care. The aim of this study was firstly to ...
Summary Invasive mucinous adenocarcinoma is a variant of lung adenocarcinoma, which may be mixed with nonmucinous adenocarcinoma. KRAS mutations are common... Boland,Jennifer,M.,... - 《Human Pathology》 被引量: 0发表: 2018年 Pulmonary Invasive Mucinous Adenocarcinoma and Mixed Invasive Mucinous/No...
· Invasive adenocarcinoma, predominant growth pattern: lepidic >5 mm of invasion, acinar, papillary, micropapillary, or solid with mucin · Invasive adenocarcinoma variants: mucinous adenocarcinoma, colloid, fetal, and enteric morphologies. Note: All recommendations are category 2A unless otherwise ...
(NSCLC) was published in 2000, with no mention of the advancing molecular age,1 and although the 2004 WHO classification of lung tumours introduced relevant genetic data,2 rapid development in this area has necessitated an almost immediate update, specifically relating to adenocarcinoma and diagnosis...
It is highly conceivable that this de novo expression of MUC2 has a role, not only in the mucinous differentiation of these tumors and their colloid pattern, but also in their relatively indol 展开 关键词: MUC2 mucinous adenocarcinoma nonmucinous adenocarcinoma ...
Kadota K, Villena-Vargas J, Yoshizawa A, Motoi N, Sima CS, Riely GJ, Rusch VW, Adusumilli PS, Travis WD (2014) Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I...
Kadota K, Villena-Vargas J, Yoshizawa A et al (2014) Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol 38:448–460 CrossRef Petersen I,...
Chemotherapy or chemoradiation is often used in Stage IIIA non–small cell lung carcinoma before surgical resection (neoadjuvant therapy). In reviewing the histopathology of such tumors after resection, the recognition that the pathologic changes are rel